Loading…

Contrast-Enhanced Ultrasound Imaging of Intraplaque Neovascularization in Carotid Arteries

Contrast-Enhanced Ultrasound Imaging of Intraplaque Neovascularization in Carotid Arteries: Correlation With Histology and Plaque Echogenicity Stefano Coli, Marco Magnoni, Giuseppe Sangiorgi, Massimiliano M. Marrocco-Trischitta, Giulio Melisurgo, Alessandro Mauriello, Luigi Spagnoli, Roberto Chiesa,...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2008-07, Vol.52 (3), p.223-230
Main Authors: Coli, Stefano, MD, Magnoni, Marco, MD, Sangiorgi, Giuseppe, MD, FESC, Marrocco-Trischitta, Massimiliano M., MD, Melisurgo, Giulio, MD, Mauriello, Alessandro, MD, Spagnoli, Luigi, MD, Chiesa, Roberto, MD, Cianflone, Domenico, MD, FESC, Maseri, Attilio, MD, FACC
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Contrast-Enhanced Ultrasound Imaging of Intraplaque Neovascularization in Carotid Arteries: Correlation With Histology and Plaque Echogenicity Stefano Coli, Marco Magnoni, Giuseppe Sangiorgi, Massimiliano M. Marrocco-Trischitta, Giulio Melisurgo, Alessandro Mauriello, Luigi Spagnoli, Roberto Chiesa, Domenico Cianflone, Attilio Maseri Plaque neovascularization is associated with vulnerable and symptomatic atherosclerosis; therefore, we have evaluated carotid contrast-enhanced ultrasound imaging as a clinical tool to study intraplaque neovascularization. Thirty-two patients with 52 plaques were studied. In 17 patients, the surgical specimen was available for histological determination of microvessel density. In the surgical subgroup, plaques with higher contrast-agent enhancement showed a greater microvessel density. In the whole series of 52 lesions, echolucent plaques showed a greater contrast-agent enhancement. Contrast-enhanced ultrasound imaging can be used to study carotid plaque neovascularization and may become a tool to identify vulnerable plaques and monitor response to therapy.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2008.02.082